Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Gynecol Oncol. 2010 Sep 17;119(3):462–468. doi: 10.1016/j.ygyno.2010.08.028

Table 2.

Correlations between CA125 levels and continuous variables.

Variable Non-
mucinous
invasive
cases
N=636
r (p)
Serous
borderline
N=84
r (p)
Mucinous
borderline
N=40
r (p)
Serous
invasive
N=407
r (p)
Clear cell
invasive
N=35
r (p)
Endometrioid
invasive
N=92
r (p)
Mucinous
invasive
N=31
r (p)
Age 0.02
(0.60)
−0.23
(0.03)
−0.18
(0.28)
−0.11
(0.03)
−0.16
(0.37)
0.09
(0.40)
0.23
(0.21)
Age,
quadratic*
0.02
(0.004)
0.05
(0.10)
0.03
(0.55)
0.02
(0.04)
0.06
(0.40)
0.06
(0.07)
0.05
(0.47)
Years since
natural
menopause
−0.11
(0.04)
−0.18
(0.31)
−0.15
(0.55)
−0.10
(0.11)
−0.40
(0.14)
−0.14
(0.48)
0.26
(0.33)
Years since
natural
menopause or
hysterectomy
−0.10
(0.05)
−0.16
(0.32)
−0.27
(0.23)
−0.11
(0.05)
−0.35
(0.17)
−0.09
(0.62)
0.27
(0.29)
BMI −0.06
(0.11)
−0.13
(0.23)
−0.10
(0.54)
−0.01
(0.89)
−0.04
(0.81)
−0.05
(0.65)
0.12
(0.55)
Ovulatory
cycles
0.04
(0.37)
−0.01
(0.99)
−0.29
(0.23)
−0.06
(0.36)
0.20
(0.35)
0.23
(0.06)
0.17
(0.52)
*

A correlation coefficient cannot be defined for a quadratic model. The top number in this row is the proportion of variability explained by each linear regression model with terms for age and age2 and the p-value is the p-value for the overall model.

This data available for post-op study cases only.